617 related articles for article (PubMed ID: 15193340)
1. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
Swerdlow RH; Khan SM
Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice.
Hauptmann S; Scherping I; Dröse S; Brandt U; Schulz KL; Jendrach M; Leuner K; Eckert A; Müller WE
Neurobiol Aging; 2009 Oct; 30(10):1574-86. PubMed ID: 18295378
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.
Hauptmann S; Keil U; Scherping I; Bonert A; Eckert A; Müller WE
Exp Gerontol; 2006 Jul; 41(7):668-73. PubMed ID: 16677790
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
Reddy PH
J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
[TBL] [Abstract][Full Text] [Related]
6. Role of mitochondrial amyloid-beta in Alzheimer's disease.
Chen JX; Yan SS
J Alzheimers Dis; 2010; 20 Suppl 2():S569-78. PubMed ID: 20463403
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity.
Cardoso SM; Santana I; Swerdlow RH; Oliveira CR
J Neurochem; 2004 Jun; 89(6):1417-26. PubMed ID: 15189344
[TBL] [Abstract][Full Text] [Related]
8. Modeling sporadic Alzheimer's disease: the insulin resistant brain state generates multiple long-term morphobiological abnormalities including hyperphosphorylated tau protein and amyloid-beta.
Salkovic-Petrisic M; Osmanovic J; Grünblatt E; Riederer P; Hoyer S
J Alzheimers Dis; 2009; 18(4):729-50. PubMed ID: 19661616
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
Roy S; Rauk A
Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
[TBL] [Abstract][Full Text] [Related]
10. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis.
Castellani RJ; Smith MA; Perry G; Friedland RP
Neurobiol Aging; 2004; 25(5):599-602; discussion 603-4. PubMed ID: 15172735
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Abeta: a potential cause of metabolic dysfunction in Alzheimer's disease.
Chen X; Yan SD
IUBMB Life; 2006 Dec; 58(12):686-94. PubMed ID: 17424907
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease.
Anandatheerthavarada HK; Devi L
Neuroscientist; 2007 Dec; 13(6):626-38. PubMed ID: 17911214
[TBL] [Abstract][Full Text] [Related]
15. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease.
Wang X; Su B; Perry G; Smith MA; Zhu X
Free Radic Biol Med; 2007 Dec; 43(12):1569-73. PubMed ID: 18037122
[TBL] [Abstract][Full Text] [Related]
16. Cerebral amyloid angiopathy and dementia.
Tian J; Shi J; Mann DM
Panminerva Med; 2004 Dec; 46(4):253-64. PubMed ID: 15876981
[TBL] [Abstract][Full Text] [Related]
17. Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction.
Lim YA; Rhein V; Baysang G; Meier F; Poljak A; Raftery MJ; Guilhaus M; Ittner LM; Eckert A; Götz J
Proteomics; 2010 Apr; 10(8):1621-33. PubMed ID: 20186753
[TBL] [Abstract][Full Text] [Related]
18. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
Van Broeck B; Van Broeckhoven C; Kumar-Singh S
Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
[TBL] [Abstract][Full Text] [Related]
19. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
Atamna H; Frey WH
Mitochondrion; 2007 Sep; 7(5):297-310. PubMed ID: 17625988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
